Bridging Levels of Understanding in Schizophrenia Through Computational Modeling

被引:30
作者
Anticevic, Alan [1 ,2 ,3 ]
Murray, John D. [4 ]
Barch, Deanna M. [5 ,6 ]
机构
[1] Yale Univ, Dept Psychiat, 34 Pk St, New Haven, CT 06519 USA
[2] Natl Inst Alcohol Abuse & Alcoholism, Ctr Translat Neurosci Alcoholism, New Haven, CT 06516 USA
[3] Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, New Haven, CT 06516 USA
[4] NYU, Ctr Neural Sci, New York, NY 10003 USA
[5] Washington Univ, Dept Psychol, St Louis, MO 63130 USA
[6] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA
基金
美国国家卫生研究院;
关键词
computational modeling; schizophrenia; symptoms; cognitive deficits; systems neuroscience;
D O I
10.1177/2167702614562041
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Schizophrenia is an illness with a remarkably complex symptom presentation that has thus far been out of reach of neuroscientific explanation. This presents a fundamental problem for developing better treatments that target specific symptoms or root causes. One promising path forward is the incorporation of computational neuroscience, which provides a way to formalize experimental observations and, in turn, make theoretical predictions for subsequent studies. We review three complementary approaches: (a) biophysically based models developed to test cellular-level and synaptic hypotheses, (b) connectionist models that give insight into large-scale neural-system-level disturbances in schizophrenia, and (c) models that provide a formalism for observations of complex behavioral deficits, such as negative symptoms. We argue that harnessing all of these modeling approaches represents a productive approach for better understanding schizophrenia. We discuss how blending these approaches can allow the field to progress toward a more comprehensive understanding of schizophrenia and its treatment.
引用
收藏
页码:433 / 459
页数:27
相关论文
共 178 条
  • [91] Human pharmacological MRI
    Honey, G
    Bullmore, ET
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (07) : 366 - 374
  • [92] The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
    Howes, Oliver D.
    Kambeitz, Joseph
    Kim, Euitae
    Stahl, Daniel
    Slifstein, Mark
    Abi-Dargham, Anissa
    Kapur, Shitij
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2012, 69 (08) : 776 - 786
  • [93] The mind and brain of short-term memory
    Jonides, John
    Lewis, Richard L.
    Nee, Derek Evan
    Lustig, Cindy
    Berman, Marc G.
    Moore, Katherine Sledge
    [J]. ANNUAL REVIEW OF PSYCHOLOGY, 2008, 59 : 193 - 224
  • [94] From dopamine to salience to psychosis - linking biology, pharmacology and phenomenology of psychosis
    Kapur, S
    Mizrahi, R
    Li, M
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 79 (01) : 59 - 68
  • [95] Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia
    Kapur, S
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (01) : 13 - 23
  • [96] Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia
    Karlsgodt, Katherine H.
    Sanz, Jacqueline
    van Erp, Theo G. M.
    Bearden, Carrie E.
    Nuechterlein, Keith H.
    Cannon, Tyrone D.
    [J]. SCHIZOPHRENIA RESEARCH, 2009, 108 (1-3) : 143 - 150
  • [97] Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
    Kegeles, Lawrence S.
    Abi-Dargham, Anissa
    Frankle, Gordon
    Gil, Roberto
    Cooper, Thomas B.
    Slifstein, Mark
    Hwang, Dah-Ren
    Huang, Yiyun
    Haber, Suzanne N.
    Laruelle, Marc
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (03) : 231 - 239
  • [98] Dopamine and gamma band synchrony in schizophrenia - insights from computational and empirical studies
    Koemek, Kuebra
    Ermentrout, G. Bard
    Walker, Christopher P.
    Cho, Raymond Y.
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2012, 36 (02) : 2146 - 2155
  • [99] Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
    Kotermanski, Shawn E.
    Johnson, Jon W.
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (09) : 2774 - 2779
  • [100] SUBANESTHETIC EFFECTS OF THE NONCOMPETITIVE NMDA ANTAGONIST, KETAMINE, IN HUMANS - PSYCHOTOMIMETIC, PERCEPTUAL, COGNITIVE, AND NEUROENDOCRINE RESPONSES
    KRYSTAL, JH
    KARPER, LP
    SEIBYL, JP
    FREEMAN, GK
    DELANEY, R
    BREMNER, JD
    HENINGER, GR
    BOWERS, MB
    CHARNEY, DS
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) : 199 - 214